Dilek Duzgun Ergun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dilek Duzgun Ergun has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Nural Pastacı Özsobacı
Department of Biophysics, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkiye
7 shared publications - Hafize Uzun
Department of Biochemistry, Faculty of Medicine, Istanbul Atlas University, Istanbul 34408, Turkey
5 shared publications Dervis Ozcelik
Department of Biophysics, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey
4 shared publications- Sefa Ergün
Istanbul University-Cerrahpasa
4 shared publications - Ahu Soyocak
Faculty of Medicine, Department of Medical Biology, Istanbul Aydın University, Istanbul, Türkiye
3 shared publications - Seyma Dumur
Department of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Turkey
3 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (10) , 1556
Combined Effects of ATRA and ASA on HeLa Cell Viability, MAPK/AKT-Related Protein Abundance, and Intracellular VEGF: An Integrated In Vitro and In Silico Study
Background/Objectives: All-trans retinoic acid (ATRA) and acetylsalicylic acid (ASA; aspirin) have been reported to influence cancer-associated signaling through distinct molecular mechanisms, but their combined effects on cervical cancer cells remain incompletely characterized. This study evaluated the individual and combined effects of ATRA and ASA on HeLa human cervical cancer cells and used computational analyses as supportive, hypothesis-generating mechanistic contextualization. Methods: Cell viability was assessed by MTT assay after treatment with increasing concentrations of ATRA and ASA for 24, 48, and 72 h. The abundance of total ERK1/2, phospho-AKT (Ser473), total p38 MAPK, and total JNK was assessed by Western blotting, while intracellular HIF-1α and VEGF concentrations were measured in cell lysates by ELISA. Computational analyses included cross-validated response modeling, bootstrap estimation of Bliss excess inhibition, STRING network topology and enrichment, SwissTargetPrediction/SEA consensus target prediction, TCGA-CESC survival analysis, and redocking-validated molecular docking. Results: ATRA and ASA reduced HeLa cell viability in a dose- and time-dependent manner. Treatment was associated with lower total ERK1/2 abundance and lower phospho-AKT (Ser473) abundance, whereas ASA-containing conditions were associated with higher stress-associated MAPK markers, particularly JNK. Intracellular VEGF concentrations were lower after ATRA, ASA, and combined treatment, while intracellular HIF-1α concentrations were not significantly altered under normoxic culture conditions. Computational response modeling showed high predictive accuracy for ATRA and ASA, while bootstrap Bliss analysis indicated dose-dependent interaction behavior rather than uniform synergy. STRING analysis supported pathway-level coherence among retinoid, COX/prostaglandin, MAPK/AKT, hypoxia, and angiogenesis-related modules. TCGA-CESC analyses associated VEGFA, HIF1A, and PTGS2 with adverse survival outcomes in adjusted models. Docking supported ATRA–RARG and salicylate–COX-2 pose plausibility but did not support direct VEGFR2 or AKT1 targeting by ASA or salicylate. Conclusions: These findings suggest that ATRA and ASA reduce HeLa cell viability and are associated with altered MAPK/AKT-related protein abundance and lower intracellular VEGF concentrations in HeLa cervical cancer cells. The computational results provide pathway-level support and target prioritization for future validation but should not be interpreted as proof of direct binding, causal pathway mediation, treatment efficacy, or clinical benefit.
- 1 October 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (10) , 1556
Open AccessCombined Effects of ATRA and ASA on HeLa Cell Viability, MAPK/AKT-Related Protein Abundance, and Intracellular VEGF: An Integrated In Vitro and In Silico Study
Background/Objectives: All-trans retinoic acid (ATRA) and acetylsalicylic acid (ASA; aspirin) have been reported to influence cancer-associated signaling through distinct molecular mechanisms, but their combined effects on cervical cancer cells remain incompletely characterized. This study evaluated the individual and combined effects of ATRA and ASA on HeLa human cervical cancer cells and used computational analyses as supportive, hypothesis-generating mechanistic contextualization. Methods: Cell viability was assessed by MTT assay after treatment with increasing concentrations of ATRA and ASA for 24, 48, and 72 h. The abundance of total ERK1/2, phospho-AKT (Ser473), total p38 MAPK, and total JNK was assessed by Western blotting, while intracellular HIF-1α and VEGF concentrations were measured in cell lysates by ELISA. Computational analyses included cross-validated response modeling, bootstrap estimation of Bliss excess inhibition, STRING network topology and enrichment, SwissTargetPrediction/SEA consensus target prediction, TCGA-CESC survival analysis, and redocking-validated molecular docking. Results: ATRA and ASA reduced HeLa cell viability in a dose- and time-dependent manner. Treatment was associated with lower total ERK1/2 abundance and lower phospho-AKT (Ser473) abundance, whereas ASA-containing conditions were associated with higher stress-associated MAPK markers, particularly JNK. Intracellular VEGF concentrations were lower after ATRA, ASA, and combined treatment, while intracellular HIF-1α concentrations were not significantly altered under normoxic culture conditions. Computational response modeling showed high predictive accuracy for ATRA and ASA, while bootstrap Bliss analysis indicated dose-dependent interaction behavior rather than uniform synergy. STRING analysis supported pathway-level coherence among retinoid, COX/prostaglandin, MAPK/AKT, hypoxia, and angiogenesis-related modules. TCGA-CESC analyses associated VEGFA, HIF1A, and PTGS2 with adverse survival outcomes in adjusted models. Docking supported ATRA–RARG and salicylate–COX-2 pose plausibility but did not support direct VEGFR2 or AKT1 targeting by ASA or salicylate. Conclusions: These findings suggest that ATRA and ASA reduce HeLa cell viability and are associated with altered MAPK/AKT-related protein abundance and lower intracellular VEGF concentrations in HeLa cervical cancer cells. The computational results provide pathway-level support and target prioritization for future validation but should not be interpreted as proof of direct binding, causal pathway mediation, treatment efficacy, or clinical benefit.
- Open Access
Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 Cardiomyocytes
Background and Objectives: Cardiovascular disease remains a leading cause of mortality in Diabetes mellitus (DM), where chronic hyperglycemia induces oxidative stress, mitochondrial dysfunction, and hypoxia in cardiomyocytes. Liraglutide (Lir), a glucagon-like peptide-1 receptor agonist, is widely used for type 2 DM management and has been shown to exert cardioprotective and antioxidant effects. This study aimed to evaluate whether Lir mitigates hyperglycemia-induced oxidative and hypoxic stress in H9c2 cardiomyoblasts while preserving cellular ultrastructure. Materials and Methods: H9c2 cells were cultured under normoglycemic (5.5 mM) or hyperglycemic (30 mM) conditions, with or without Lir. Cell viability was assessed using MTT assay. Ultrastructural changes were examined by transmission electron microscopy (TEM). Hypoxia-inducible factor-1α (HIF-1α), lipid peroxidation markers (LOOH, MDA), advanced oxidation protein products (AOPP), and total antioxidant capacity (TAC) were quantified by spectrophotometric assays. Results: MTT assays revealed that Lir significantly improved cell viability under hyperglycemic conditions and the EC50 was 1.05 ± 0.06 μM after 48 h of treatment. Under HG, HIF-1α, lipid hydroperoxides (LOOH), malondialdehyde (MDA) and advanced oxidation protein products (AOPP) increased and total antioxidant capacity (TAC) decreased (p < 0.001, for all); Lir significantly reversed these changes, restoring values to near-NG levels. Ultrastructural analysis of HG + Lir-treated cells revealed reduced granules, increased vacuolization, and slight rough endoplasmic reticulum dilatation, though mitochondria appeared normal. Conclusions: Lir significantly attenuated oxidative stress and cellular injury in cardiomyocytes under hyperglycemic conditions, improving viability, modulating HIF-1α expression, and restoring antioxidant balance. These findings support a dual role for Lir in diabetic cardiomyopathy: glucose-independent cytoprotection and regulation of mitochondrial and hypoxia pathways, highlighting its therapeutic potential beyond glycemic control.
Open AccessLiraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 Cardiomyocytes
Background and Objectives: Cardiovascular disease remains a leading cause of mortality in Diabetes mellitus (DM), where chronic hyperglycemia induces oxidative stress, mitochondrial dysfunction, and hypoxia in cardiomyocytes. Liraglutide (Lir), a glucagon-like peptide-1 receptor agonist, is widely used for type 2 DM management and has been shown to exert cardioprotective and antioxidant effects. This study aimed to evaluate whether Lir mitigates hyperglycemia-induced oxidative and hypoxic stress in H9c2 cardiomyoblasts while preserving cellular ultrastructure. Materials and Methods: H9c2 cells were cultured under normoglycemic (5.5 mM) or hyperglycemic (30 mM) conditions, with or without Lir. Cell viability was assessed using MTT assay. Ultrastructural changes were examined by transmission electron microscopy (TEM). Hypoxia-inducible factor-1α (HIF-1α), lipid peroxidation markers (LOOH, MDA), advanced oxidation protein products (AOPP), and total antioxidant capacity (TAC) were quantified by spectrophotometric assays. Results: MTT assays revealed that Lir significantly improved cell viability under hyperglycemic conditions and the EC50 was 1.05 ± 0.06 μM after 48 h of treatment. Under HG, HIF-1α, lipid hydroperoxides (LOOH), malondialdehyde (MDA) and advanced oxidation protein products (AOPP) increased and total antioxidant capacity (TAC) decreased (p < 0.001, for all); Lir significantly reversed these changes, restoring values to near-NG levels. Ultrastructural analysis of HG + Lir-treated cells revealed reduced granules, increased vacuolization, and slight rough endoplasmic reticulum dilatation, though mitochondria appeared normal. Conclusions: Lir significantly attenuated oxidative stress and cellular injury in cardiomyocytes under hyperglycemic conditions, improving viability, modulating HIF-1α expression, and restoring antioxidant balance. These findings support a dual role for Lir in diabetic cardiomyopathy: glucose-independent cytoprotection and regulation of mitochondrial and hypoxia pathways, highlighting its therapeutic potential beyond glycemic control.
- Open Access
- 19 August 2025
- Published by AVES YAYINCILIK A.Ş. in Cerrahpasa Medical Journal
- Vol. 49 (1) , 1-7
Analyzing Methotrexate’s Impact on Oxidative Stress Indicators in Breast Cancer Cells
Objective: Methotrexate (MTX) is one of the most commonly used antiproliferative chemotherapeutic agents. In addition to its antiproliferative effect, MTX may also play a role in the induction of oxidative stress. This study investigates the effects of MTX on cell cytotoxicity and oxidative stress markers (superoxide dismutase [SOD] activity, malondialdehyde [MDA] levels), and total thiol content) in both human healthy breast cells (hTERT-HME1) and human breast cancer cells (MCF-7). Methods: The hTERT-HME1 and MCF-7 cell lines were divided into untreated control and MTX groups. The cell viability assay was carried out using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Superoxide dismutase, MDA, and total thiol levels were measured spectrophotometrically. Results: The effects of MTX on cell viability were observed after treatment of hTERT-HME1 and MCF-7 for 24, 48, and 72 hours. In comparison to MCF-7 cells, hTERT-HME1 cells exhibited increased cell survival and half-maximum inhibitory concentration 50 values after MTX treatment. Methotrexate administration also significantly decreased SOD and total thiol levels and increased MDA levels in both cell types. Conclusion: This study suggests that MTX has high anticancer activity through its effects on cell viability and oxidative stress. However, observation of similar effects in healthy cells requires the development of various combination therapies or targeted drug delivery systems to reduce the side effects of MTX. Cite this article as: Durmuş S, Ergün DD, Gelişgen R, Bakır N, Uzun H. Analyzing methotrexate’s impact on oxidative stress indicators in breast cancer cells. Cerrahpaşa Med J 2025, 49, 0007, doi: 10.5152/cjm.2025.25007.
- 19 August 2025
- Published by AVES YAYINCILIK A.Ş. in Cerrahpasa Medical Journal
- Vol. 49 (1) , 1-7
Open AccessAnalyzing Methotrexate’s Impact on Oxidative Stress Indicators in Breast Cancer Cells
Objective: Methotrexate (MTX) is one of the most commonly used antiproliferative chemotherapeutic agents. In addition to its antiproliferative effect, MTX may also play a role in the induction of oxidative stress. This study investigates the effects of MTX on cell cytotoxicity and oxidative stress markers (superoxide dismutase [SOD] activity, malondialdehyde [MDA] levels), and total thiol content) in both human healthy breast cells (hTERT-HME1) and human breast cancer cells (MCF-7). Methods: The hTERT-HME1 and MCF-7 cell lines were divided into untreated control and MTX groups. The cell viability assay was carried out using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Superoxide dismutase, MDA, and total thiol levels were measured spectrophotometrically. Results: The effects of MTX on cell viability were observed after treatment of hTERT-HME1 and MCF-7 for 24, 48, and 72 hours. In comparison to MCF-7 cells, hTERT-HME1 cells exhibited increased cell survival and half-maximum inhibitory concentration 50 values after MTX treatment. Methotrexate administration also significantly decreased SOD and total thiol levels and increased MDA levels in both cell types. Conclusion: This study suggests that MTX has high anticancer activity through its effects on cell viability and oxidative stress. However, observation of similar effects in healthy cells requires the development of various combination therapies or targeted drug delivery systems to reduce the side effects of MTX. Cite this article as: Durmuş S, Ergün DD, Gelişgen R, Bakır N, Uzun H. Analyzing methotrexate’s impact on oxidative stress indicators in breast cancer cells. Cerrahpaşa Med J 2025, 49, 0007, doi: 10.5152/cjm.2025.25007.
- Open Access
Association of Helicobacter pylori with Serum HIF-1α, HIF-2α, and Human Transmembrane Prolyl 4-Hydroxylase Activity in Patients with Chronic Gastritis
Background and Objectives: Chronic mucosal infection with Helicobacter pylori (H. pylori) plays a key role in the development of gastroduodenal disorders such as chronic gastritis, peptic ulcers, gastric lymphoma, and gastric cancer by triggering local immune responses and inducing hypoxic and inflammatory conditions in the gastric mucosa. This study aims to evaluate the potential diagnostic value of hypoxia-inducible factors HIF-1α and HIF-2α, along with transmembrane prolyl 4-hydroxylase (P4H-TM), as biomarkers in H. pylori-positive patients. Additionally, the study investigates the association between these markers and alterations in lipid profiles, as well as their involvement in the molecular mechanisms underlying gastric conditions like gastritis, particularly in the context of H. pylori infection. Materials and Methods: This study was conducted at Istanbul Avcılar Murat Kölük State Hospital’s General Surgery Outpatient Clinic. A total of 60 participants were included: 40 patients diagnosed with chronic gastritis (20 H. pylori-positive and 20 H. pylori-negative) and 20 healthy controls confirmed negative by 13C-urea breath test. Blood samples were collected for ELISA analysis of HIF-1α, HIF-2α, and P4H-TM levels. Additionally, lipid profiles were measured and compared among the groups. Results: No significant differences were found among the groups in terms of demographic factors such as age, sex, or body mass index (BMI). However, significant variations were observed in the levels of HIF-1α, HIF-2α, and P4H-TM across all groups (p < 0.001 for each marker). These markers were substantially elevated in the H. pylori-positive gastritis group compared to both the H. pylori-negative and healthy control groups. Receiver Operating Characteristic (ROC) curve analysis revealed that all evaluated markers exhibited strong diagnostic accuracy in differentiating H. pylori-positive individuals from other groups. HIF-1α (AUC: 0.983) and HIF-2α (AUC: 0.981) both achieved 100% sensitivity with specificities of 93.3% and 91.1%, respectively. P4H-TM showed an AUC of 0.927, with 85% sensitivity and 95.6% specificity. Conclusions: These findings indicate that HIF-1α, HIF-2α, and P4H-TM may serve as effective biomarkers for diagnosing H. pylori-positive patients and may be linked to changes in lipid metabolism. The elevated expression of these markers in response to H. pylori infection highlights their potential roles in the inflammatory and hypoxic pathways that contribute to the pathogenesis of gastric diseases such as gastritis.
Open AccessAssociation of Helicobacter pylori with Serum HIF-1α, HIF-2α, and Human Transmembrane Prolyl 4-Hydroxylase Activity in Patients with Chronic Gastritis
Background and Objectives: Chronic mucosal infection with Helicobacter pylori (H. pylori) plays a key role in the development of gastroduodenal disorders such as chronic gastritis, peptic ulcers, gastric lymphoma, and gastric cancer by triggering local immune responses and inducing hypoxic and inflammatory conditions in the gastric mucosa. This study aims to evaluate the potential diagnostic value of hypoxia-inducible factors HIF-1α and HIF-2α, along with transmembrane prolyl 4-hydroxylase (P4H-TM), as biomarkers in H. pylori-positive patients. Additionally, the study investigates the association between these markers and alterations in lipid profiles, as well as their involvement in the molecular mechanisms underlying gastric conditions like gastritis, particularly in the context of H. pylori infection. Materials and Methods: This study was conducted at Istanbul Avcılar Murat Kölük State Hospital’s General Surgery Outpatient Clinic. A total of 60 participants were included: 40 patients diagnosed with chronic gastritis (20 H. pylori-positive and 20 H. pylori-negative) and 20 healthy controls confirmed negative by 13C-urea breath test. Blood samples were collected for ELISA analysis of HIF-1α, HIF-2α, and P4H-TM levels. Additionally, lipid profiles were measured and compared among the groups. Results: No significant differences were found among the groups in terms of demographic factors such as age, sex, or body mass index (BMI). However, significant variations were observed in the levels of HIF-1α, HIF-2α, and P4H-TM across all groups (p < 0.001 for each marker). These markers were substantially elevated in the H. pylori-positive gastritis group compared to both the H. pylori-negative and healthy control groups. Receiver Operating Characteristic (ROC) curve analysis revealed that all evaluated markers exhibited strong diagnostic accuracy in differentiating H. pylori-positive individuals from other groups. HIF-1α (AUC: 0.983) and HIF-2α (AUC: 0.981) both achieved 100% sensitivity with specificities of 93.3% and 91.1%, respectively. P4H-TM showed an AUC of 0.927, with 85% sensitivity and 95.6% specificity. Conclusions: These findings indicate that HIF-1α, HIF-2α, and P4H-TM may serve as effective biomarkers for diagnosing H. pylori-positive patients and may be linked to changes in lipid metabolism. The elevated expression of these markers in response to H. pylori infection highlights their potential roles in the inflammatory and hypoxic pathways that contribute to the pathogenesis of gastric diseases such as gastritis.
- Open Access
- 10 June 2024
- Published by MDPI AG in Preprints.org
Effects of the Methotrexate on HIF-1α, HIF-2α and P4H-TM Levels in Breast Cancer Cells: Results from an In Vitro Study
Background: Methotrexate (MTX) displayed cytotoxic properties against some cancer cells. However, there is very limited data about the possible anti-tumoral potential of them in breast cancer (BC) cells. We aimed to determine the effects of MTX, which is widely used in clinical practice, on cell viability, Hypoxia-inducible factor (HIF) -1α, HIF-2α and prolyl 4-hydroxylase-transmembrane (P4H-TM) in BC cells (MCF-7) and health breast cell (HTERT-HME1) treated with MTX. Methods: Human healthy breast cells (HTERT-HME1) and BC cells (MCF-7) treated with MTX for 24 h, 48h, and 72 h, the effects of MTX on cell viability. Results: The cell viability and with half-maximal inhibitory concentration (IC50) values of of MTX treatment in healthy breast cells were determined to be higher than in MCF-7 cells. MTX showed higher cytotoxicity against MCF-7 cells. MTX significantly reduced cell viability values in HTERT-HME1 and MCF-7 cells. HIF-1α, HIF-2α, and P4H-TM levels was significantly higher in the MCF-7 group than the other groups. Morever, there was a moderate significant correlation between HIF-1α and HIF-2α levels and between HIF-1α and P4H-TM. Conclusions: MTX will show a further decrease in cell viability in long-term treatments of 48 and 72 hours, it is predicted that short-term use may be more appropriate. P4H-TM may be a novel regulator of hypoxia in BC cells. HIF-1α, a key protein responsible for the molecular mechanism of hypoxia in cells, is a key mediator between P4H-TM and hypoxia in MTX-treated cells. HIF-1α, HIF-2α, and P4H-TM values may be markers that can be used as a panel to differentiate BC from healthy women.
- 10 June 2024
- Published by MDPI AG in Preprints.org
Open AccessEffects of the Methotrexate on HIF-1α, HIF-2α and P4H-TM Levels in Breast Cancer Cells: Results from an In Vitro Study
Background: Methotrexate (MTX) displayed cytotoxic properties against some cancer cells. However, there is very limited data about the possible anti-tumoral potential of them in breast cancer (BC) cells. We aimed to determine the effects of MTX, which is widely used in clinical practice, on cell viability, Hypoxia-inducible factor (HIF) -1α, HIF-2α and prolyl 4-hydroxylase-transmembrane (P4H-TM) in BC cells (MCF-7) and health breast cell (HTERT-HME1) treated with MTX. Methods: Human healthy breast cells (HTERT-HME1) and BC cells (MCF-7) treated with MTX for 24 h, 48h, and 72 h, the effects of MTX on cell viability. Results: The cell viability and with half-maximal inhibitory concentration (IC50) values of of MTX treatment in healthy breast cells were determined to be higher than in MCF-7 cells. MTX showed higher cytotoxicity against MCF-7 cells. MTX significantly reduced cell viability values in HTERT-HME1 and MCF-7 cells. HIF-1α, HIF-2α, and P4H-TM levels was significantly higher in the MCF-7 group than the other groups. Morever, there was a moderate significant correlation between HIF-1α and HIF-2α levels and between HIF-1α and P4H-TM. Conclusions: MTX will show a further decrease in cell viability in long-term treatments of 48 and 72 hours, it is predicted that short-term use may be more appropriate. P4H-TM may be a novel regulator of hypoxia in BC cells. HIF-1α, a key protein responsible for the molecular mechanism of hypoxia in cells, is a key mediator between P4H-TM and hypoxia in MTX-treated cells. HIF-1α, HIF-2α, and P4H-TM values may be markers that can be used as a panel to differentiate BC from healthy women.
- 25 August 2023
- Published by Galenos Yayinevi in Journal of Academic Research in Medicine
- Vol. 13 (2) , 58-62
Synthesis of Graphene Oxide and in vitro Evaluation of Its Cytotoxic Effect
- 25 August 2023
- Published by Galenos Yayinevi in Journal of Academic Research in Medicine
- Vol. 13 (2) , 58-62
Synthesis of Graphene Oxide and in vitro Evaluation of Its Cytotoxic Effect
- 3 July 2023
- Published by Taylor & Francis in Electromagnetic Biology and Medicine
- Vol. 42 (3) , 123-132
Assessing the effect of selenium on cyclin D1 level and nuclear factor kappa b activity in NIH/3T3 fibroblast cells at 2100 MHz electromagnetic field exposure
Although there are numerous studies on the health impacts of electromagnetic field (EMF) of mobile phone operation frequency 2100 MHz, the published works present contradicting results. Long-term exposure to mobile phone frequencies has unclear health hazards. Therefore, it is important to investigate the molecular mechanism of possible biological effects in mobile phone exposure and to determine the corresponding biological markers. Towards this end, this study was designed to assess the effect of 200 nM selenium (Se) on cell viability% [trypan blue], cell cycle biomarker [cyclin D1] and the transcription factor [nuclear factor kappa b (NF-κB)] in NIH/3T3 fibroblast cells when exposed to 2100 MHz mobile phone frequency. When 2100 MHz EMF was exposed to NIH/3T3 fibroblast cells, the cell viability% was reduced, whereas cyclin D1 level and NF-kB activity increased. Also we show that Se supplementation decreases the effects of 2100 MHz EMF on these parameters. Although future studies will be required to investigate the biological effects of EMF emitted by mobile phones, the results obtained here provide an insight into the molecular mechanisms and specifically underlying selenium's protective effect against 2100 MHz EMF exposure.
- 3 July 2023
- Published by Taylor & Francis in Electromagnetic Biology and Medicine
- Vol. 42 (3) , 123-132
Assessing the effect of selenium on cyclin D1 level and nuclear factor kappa b activity in NIH/3T3 fibroblast cells at 2100 MHz electromagnetic field exposure
Although there are numerous studies on the health impacts of electromagnetic field (EMF) of mobile phone operation frequency 2100 MHz, the published works present contradicting results. Long-term exposure to mobile phone frequencies has unclear health hazards. Therefore, it is important to investigate the molecular mechanism of possible biological effects in mobile phone exposure and to determine the corresponding biological markers. Towards this end, this study was designed to assess the effect of 200 nM selenium (Se) on cell viability% [trypan blue], cell cycle biomarker [cyclin D1] and the transcription factor [nuclear factor kappa b (NF-κB)] in NIH/3T3 fibroblast cells when exposed to 2100 MHz mobile phone frequency. When 2100 MHz EMF was exposed to NIH/3T3 fibroblast cells, the cell viability% was reduced, whereas cyclin D1 level and NF-kB activity increased. Also we show that Se supplementation decreases the effects of 2100 MHz EMF on these parameters. Although future studies will be required to investigate the biological effects of EMF emitted by mobile phones, the results obtained here provide an insight into the molecular mechanisms and specifically underlying selenium's protective effect against 2100 MHz EMF exposure.
- 19 September 2022
- Published by Academician Publishing
- p. 325-336
Nörolojik Hastalıklarda Vitamin ve Eser Elementlerin Etkisi
Nörolojik hastalıkların gelişiminde ve ilerlemesinde B12 ve D vitaminleri ile demir, çinko ve bakır gibi eser elementlerin homeostazındaki bozukluklar kritik bir rol oynamaktadır. Vitamin eksiklikleri ve eser element birikimleri, miyelin sentezinin bozulmasına, oksidatif stresin artmasına ve nöronal hasara yol açarak Alzheimer, Parkinson ve epilepsi gibi hastalıklarla ilişkilendirilmektedir. Beslenme ve antioksidan bakımından zengin diyetlerin bu nörodejeneratif süreçlerde koruyucu etki gösterdiği ve mikrobesin seviyelerinin takibinin erken tanı ile hastalık seyrinin izlenmesi açısından klinik önem taşıdığı vurgulanmaktadır. Disturbances in the homeostasis of B12 and D vitamins, along with trace elements such as iron, zinc, and copper, play a critical role in the development and progression of neurological diseases. Vitamin deficiencies and trace element accumulations lead to impaired myelin synthesis, increased oxidative stress, and neuronal damage, which are associated with conditions like Alzheimer's, Parkinson's, and epilepsy. It is emphasized that nutrition and antioxidant-rich diets have protective effects against these neurodegenerative processes, and monitoring micronutrient levels is clinically significant for early diagnosis and tracking disease progression.
- 19 September 2022
- Published by Academician Publishing
- p. 325-336
Nörolojik Hastalıklarda Vitamin ve Eser Elementlerin Etkisi
Nörolojik hastalıkların gelişiminde ve ilerlemesinde B12 ve D vitaminleri ile demir, çinko ve bakır gibi eser elementlerin homeostazındaki bozukluklar kritik bir rol oynamaktadır. Vitamin eksiklikleri ve eser element birikimleri, miyelin sentezinin bozulmasına, oksidatif stresin artmasına ve nöronal hasara yol açarak Alzheimer, Parkinson ve epilepsi gibi hastalıklarla ilişkilendirilmektedir. Beslenme ve antioksidan bakımından zengin diyetlerin bu nörodejeneratif süreçlerde koruyucu etki gösterdiği ve mikrobesin seviyelerinin takibinin erken tanı ile hastalık seyrinin izlenmesi açısından klinik önem taşıdığı vurgulanmaktadır. Disturbances in the homeostasis of B12 and D vitamins, along with trace elements such as iron, zinc, and copper, play a critical role in the development and progression of neurological diseases. Vitamin deficiencies and trace element accumulations lead to impaired myelin synthesis, increased oxidative stress, and neuronal damage, which are associated with conditions like Alzheimer's, Parkinson's, and epilepsy. It is emphasized that nutrition and antioxidant-rich diets have protective effects against these neurodegenerative processes, and monitoring micronutrient levels is clinically significant for early diagnosis and tracking disease progression.
- 24 March 2022
- Published by Springer Nature in Journal of Biological Physics
- Vol. 48 (2) , 215-226
Investigation of extracellular medium osmolality depending on zinc application and incubation time on A549 cancer cells
Changes in the osmolality of the extracellular medium (ECM) affect cell volume and cellular processes such as cell migration and proliferation. Not only may high concentrations of zinc (Zn) lead to cell death by apoptosis, but Zn is also a physiological suppressor of apoptosis. The aim of our study was to examine whether Zn and regulation of extracellular osmolality had an effect on the lung cancer cell line (A549) and how to be changed in ECM according to elements and osmolality depending on incubation time and Zn application. Our study consisted of four groups: cell-free medium, ECM of cancer cell after 24 h incubation (24hECM), ECM of cancer cell after 48 h incubation (48hECM), and ECM of cancer cell after 48 h incubation with ZnCl2 (48hECM + Zn). ECM osmolality was measured by using osmometer, and the levels of chromium (Cr), iron (Fe), and magnesium (Mg) elements were analyzed using ICP-OES device for all groups. According to the result of the analysis, a statistically significant difference was found when osmolality and element values of ECM of 24hECM and 48hECM groups were compared with the values of the 48hECM + Zn group. It was observed that there was a decrease in the levels of Cr, Fe, and Mg with Zn application and incubation period in ECM. The regulation of ECM osmolality is a promising method due to biophysical effects on cancer cells. In our study, we speculated that the understanding of the effects of Zn and osmolality with the relationship between ECM and cancer cell might lead to the discovery of biophysical approaches as a novel therapeutic strategy.
- 24 March 2022
- Published by Springer Nature in Journal of Biological Physics
- Vol. 48 (2) , 215-226
Investigation of extracellular medium osmolality depending on zinc application and incubation time on A549 cancer cells
Changes in the osmolality of the extracellular medium (ECM) affect cell volume and cellular processes such as cell migration and proliferation. Not only may high concentrations of zinc (Zn) lead to cell death by apoptosis, but Zn is also a physiological suppressor of apoptosis. The aim of our study was to examine whether Zn and regulation of extracellular osmolality had an effect on the lung cancer cell line (A549) and how to be changed in ECM according to elements and osmolality depending on incubation time and Zn application. Our study consisted of four groups: cell-free medium, ECM of cancer cell after 24 h incubation (24hECM), ECM of cancer cell after 48 h incubation (48hECM), and ECM of cancer cell after 48 h incubation with ZnCl2 (48hECM + Zn). ECM osmolality was measured by using osmometer, and the levels of chromium (Cr), iron (Fe), and magnesium (Mg) elements were analyzed using ICP-OES device for all groups. According to the result of the analysis, a statistically significant difference was found when osmolality and element values of ECM of 24hECM and 48hECM groups were compared with the values of the 48hECM + Zn group. It was observed that there was a decrease in the levels of Cr, Fe, and Mg with Zn application and incubation period in ECM. The regulation of ECM osmolality is a promising method due to biophysical effects on cancer cells. In our study, we speculated that the understanding of the effects of Zn and osmolality with the relationship between ECM and cancer cell might lead to the discovery of biophysical approaches as a novel therapeutic strategy.